5395242026-09-215395242026-09-21Disclosure15395242026-09-21Disclosure25395242026-09-21Disclosure35395242026-09-21Disclosure45395242026-09-21Disclosure5iso4217:INRxbrli:purexbrli:shares539524LALPATHLABNOTLISTEDDR. LAL PATHLABS LIMITEDVINAY GUJRALCompany Secretary and Compliance OfficerGURUGRAM2026-09-21INE600L01024Regulation 7 (2)falseEquityDesignated PersonJai Prakash Meena10000045008829000Sell550002026-09-162026-09-16Market Sale2026-09-18NSEEquityDesignated PersonSanjay Kulshreshtha3000010001425720Buy400002026-09-152026-09-15ESOP2026-09-17NAIt may be kindly noted that shares were acquired at effective Exercise price (Post Bonus Issue- 2025) of INR 1425.715/- per share under Company’s ESOP Plan. EquityOtherDr. Lal PathLabs Employee Welfare Trust7012860.004223502548749Sell6989360.00422026-09-152026-09-15ESOP2026-09-17NAIt may be kindly noted that shares were transferred at Effective Exercise price (Post Bonus Issue- 2025) of 5/-, 965.025/-,1087.47/- & 1425.715/- per share (as the case may be) under Company’s ESOP plan(s).EquityDesignated PersonNitish Rehal00800772024Buy80002026-09-152026-09-15ESOP2026-09-17NAIt may be kindly noted that shares were acquired at effective Exercise price (Post Bonus Issue- 2025) of INR 965.025/- per share under Company’s ESOP Plan and their value does not exceed the limit prescribed under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) regulations, 2015. However, the above is being informed due to the fact that the Market Value of these shares exceeds the limit prescribed under Regulation 7(2)(a). EquityDesignated PersonNitish Rehal80008001549630Sell002026-09-182026-09-18Market Sale2026-09-21NSE